R G Weleber, N G Kennaway, N R Buist. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAtrophyChoroid/pathologyDrug EvaluationHumansIn Vitro TechniquesOrnithine-Oxo-Acid Transaminase/deficiencyPyridoxine/administration & dosageRetinal Degeneration/drug therapyTransaminases/deficiencyUveal Diseases/drug therapy
Substances: See more » TransaminasesOrnithine-Oxo-Acid TransaminasePyridoxine
Year: 1978 PMID: 82193 DOI: 10.1016/s0140-6736(78)92211-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321